AKA: Alpha Yohimbine, Isoyohimbine, Corynanthidine
The Mythology: Yohimbine‘s shiny new cousin. All the fat burning magic of Yohimbine without the jitters.
The Truth: Woefully under-researched. No human obesity trials to date. Big industry spin from in vitro research and animal studies. Go for it if self-experimentation is your thing.
Research: In the late 80′s and 90′s with obesity and lifestyle research really taking off, scientists were interested in new treatment strategies for taking off pounds. Drugs acting on adrenoceptors were a natural and easy target. They were well studied and with a relatively good side effect profile. The lipid mobilising effects of alpha-receptor antagonists have been known for some time now 1 Drugs like Yohimbine, Alpha-Yohimbine and Idoxazan appeared to show promising results with rats and dogs.
Alpha Yohimbine is a stereoisomer of Yohimbine – an alpha receptor blocking drug.The rationale for Alpha Yohimbine use over Yohimbine is that it is far more specific for blocking Alpha 2 receptors than Alpha 1 receptors. 50 times more specific to be exact. (Bradley 2007) Alpha 2 receptor blockade is what results in lipid (read fat) mobilisation, as they block the reuptake of adrenalin and therefore increase ‘sympathetic’ tone ie: crudely put, more adrenaline or flight/fight chemical in your blood. Alpha 1 blockade also comes with side effects such as reduced blood pressure, jitters etc.